An autopsy case that manifested no convincing histological changes of severe renal failure after hematopoietic stem cell transplantation
- 179 Downloads
A 48-year-old Japanese woman, who had been diagnosed with smoldering adult T-cell leukemia, was admitted to our hospital for hematopoietic stem cell transplantation (HSCT) because of an acute exacerbation of her disease. After myeloablative conditioning procedures, comprising cytarabine with cyclophosphamide and total body irradiation, the HLA-matched unrelated bone marrow stem cells were infused (day 0). Her serum creatinine concentration, having been 0.6 mg/dL at baseline, began to increase from day 1 and was 2.3 mg/L on day 7. Hemodialysis was required to treat fluid overload and worsening uremia on days 8 and 9. On day 10, she presented with refractory hypotension and died due to multi-organ failure on day 12. Renal pathology at autopsy showed no specific histological changes to which her clinically severe acute kidney injury (AKI) was attributable. This case suggests that post-HSCT AKI is not necessarily accompanied by apparent renal histologic damage, even if it is clinically serious.
KeywordsAcute kidney injury Adult T-cell leukemia Urinary biomarker Cytokine Acute graft-versus-host disease
We thank Drs. Masaki Hara and Taku Morito at Division of Nephrology for their pertinent comments and practical help with writing this case report.
Conflict of interest
- 7.Lopes JA, Gonçalves S, Jorge S, Raimundo M, Resende L, Lourenço F, Lacerda JF, Martins C, do Carmo JA, Lacerda JMF, Prata MM. Contemporary analysis of the influence of acute kidney injury after reduced intensity conditioning haematopoietic cell transplantation on long-term survival. Bone Marrow Transplant. 2008;42:619–26.PubMedGoogle Scholar
- 15.Travis LB, Curtis RE, Glimelius B, Holowaty EJ, Van Leeuwen FE, Lynch CF, Hagenbeek A, Stovall M, Banks PM, Adami J, Gospodarowicz K, Wacholder S, Inskip PD, Tucker MA, Boice JD Jr. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin’s lymphoma. J Natl Cancer Inst. 1995;87:524–30.PubMedCrossRefGoogle Scholar